T. J. de Vries - Concepedia

Author

T. J. de Vries

Radboud University Nijmegen

Also Known As

T J de Vries, T. J. de Vries, T.J. De Vries, T.J. de Vries, TEUNIS J. DE VRIES, Teunis J. de Vries

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen People's Liberation Army 411 Hospital Leiden University

About

T. J. de Vries is an author at Radboud University Nijmegen specializing in tumor microenvironment, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	464
2	Pathology	7	7	450
3	Cell Biology	5	5	241
4	Immunology	4	4	404
5	Cell Signaling	1	1	48

T. J. de Vries

Publications

Citations

H-Index

Page 1

	Year	Citations
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. T. J. de Vries, A Fourkour, Th. Wobbes, PubMed ImmunologyHuman Melanocytic LesionsPathologyImmunoeditingImmunotherapeutics	1997	191
Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Nuno R. dos Santos, Ruurd Torensma, T. J. de Vries, PubMed ImmunologyPathologyAntigen ProcessingImmunotherapyTumor Biology	2000	151
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. T. J. de Vries, Paul H.A. Quax, M. Denijn, PubMed	1994	149
E-cadherin expression in human melanoma Erik H.J. Danen, T. J. de Vries, R. Morandini, Melanoma Research	1996	113
Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group T. J. de Vries, Miriam Smeets, Ruurd de Graaf, The Journal of Pathology	2001	108
Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR T. J. de Vries, A Fourkour, Cornelis J.A. Punt, British Journal of Cancer	1999	78
TETRANECTIN AND PLASMIN/PLASMINOGEN ARE SIMILARLY DISTRIBUTED AT THE INVASIVE FRONT OF CUTANEOUS MELANOMA LESIONS T. J. de Vries, P.E.J. de Wit, Inge Clemmensen, The Journal of Pathology	1996	70
Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. T. J. de Vries, Jan H. Verheijen, A C de Bart, PubMed Metastatic Cell LinesImmunologyImmunoeditingPathologyDermatology	1996	48
Components of the plasminogen activation system in uveal melanoma—a clinico‐pathological study T. J. de Vries, Cornelia M. Mooy, Michael R. van Balken, The Journal of Pathology	1995	39
Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. T. J. de Vries, J Kitson, W K Silvers, PubMed Plasminogen ActivatorsPlasminogen Activator InhibitorsCutaneous BiologyMelanomaImmunoediting	1995	18

Page 1